Research Highlights: In a Phase 1, first-in-human trial, a one-time infusion of an investigational CRISPR-Cas9 therapy targeting angiopoietin-like protein 3 (ANGPTL3) was safe and reduced LDL cholesterol by nearly 50% and reduced triglycerides by...
  • ExcessShiv@lemmy.dbzer0.comEnglish
    7·
    2 days ago

    Removing mental and physical developmental issues from future generations; yes I personally would prefer that ceases to exist.

    Or are you in bad faith trying to equate that with taking people currently alive and executing them, because that is far from the same thing.